Summary
- Current Price
- As of today, PCRX price is $25.12, down -0.97% in the most recent trading session on
- Current Price All-Time High
- PCRX price is currently -79.40% below its historical high of $121.95 set on
- Market Cap
- PCRX current market cap is $989M, down -5.30% year-over-year
- PE Ratio
- PCRX current PE ratio is 200.98
- Revenue
- PCRX current annual revenue is $726.41M, up +3.63% year-over-year
- Next Earnings
- The next earnings release for PCRX is on
Profile
| Metric | Value |
|---|---|
| Full Name | Pacira BioSciences, Inc. |
| Ticker | NASDAQ: PCRX |
| Exchange | NASDAQ |
| Sector | Healthcare |
| Industry | Specialty & Generic Drug Manufacturers |
| Country | United States |
| IPO | |
| Indexes | Not included |
| Website | pacira.com |
| Employees | 788 |
Key Metrics
| Metric | Date | Value |
|---|---|---|
| Price | $25.12 | |
| Price, 1D Change | -0.97% | |
| $989M | ||
| - | ||
| 200.98 | ||
| 0.34 | ||
| $726M | ||
| Revenue, 1Y Change | +3.63% | |
| $0.16 | ||
| EPS, 1Y Change | +107.26% |
Chart
SUGGESTED SERIES
Events
| Metric | Date | Value |
|---|---|---|
| Next Earnings | ||
| Last Qtr. Earnings | ||
| Last Ann. Earnings | ||
| Last Ex-Dividend | N/A | N/A |
| Next Ex-Dividend | N/A | N/A |
| Last Split | N/A | N/A |
| Next Split | N/A | N/A |
| Last Ticker Change | N/A | N/A |
| Next Ticker Change | N/A | N/A |
🔒 Log In To Unlock Full Data
Estimates
| Metric | Date | Value |
|---|---|---|
| $0.16 | ||
| EPS Estimate | N/A | $2.88 |
| EPS Est. Change | N/A | +1,741.87% |
| $726.41M | ||
| Revenue Estimate | N/A | $767.79M |
| Revenue Est. Change | N/A | +5.70% |
| Current Price | $25.12 | |
| Price Target | - | $28.50 |
| Price Tgt. Change | - | +13.44% |
🔒 Log In To Unlock Full Data
EPS
| Year | Estimate | Reported | Surprise / Exp. |
|---|---|---|---|
| $3.15 | -$2.15 | -168.33% | |
| $2.95 | $0.16 | -94.71% | |
| $2.88 | N/A | +1,741.87% | |
| $3.65 | N/A | +2,235.34% |
Revenue
| Year | Estimate | Reported | Surprise / Exp. |
|---|---|---|---|
| $700.50M | $700.97M | +0.07% | |
| $731.56M | $726.41M | -0.70% | |
| $767.79M | N/A | +5.70% | |
| $831.29M | N/A | +14.44% |
🔒 Log In To Unlock Full Data
Performance
Technicals
| Metric | Date | Value |
|---|---|---|
| Current Price | $25.12 | |
| $23.42 | ||
| $23.69 | ||
| $23.43 | ||
| $23.50 | ||
| $0.41 | ||
| 0.34 | ||
| $0.92 | ||
| 68.06 | ||
| 27.21% | ||
| 37.08% |
Dividends
| Metric | Date | Value |
|---|---|---|
| N/A | - | |
| Upcoming | N/A | N/A |
| - | ||
| - | ||
| $0.00 | ||
| 0.00% |
🔒 Log In To Unlock Full Data
Income & Profitability
| Metric | Date | Value |
|---|---|---|
| $726.41M | ||
| $0.16 | ||
| $0.00 | ||
| 71.50% | ||
| $28.10M | ||
| 3.87% | ||
| $7.03M | ||
| 0.97% | ||
| $119.13M |
🔒 Log In To Unlock Full Data
Financial Health
| Metric | Date | Value |
|---|---|---|
| 0.60 | ||
| 4.54 | ||
| 3.28 | ||
| - | ||
| 9 | ||
| 1.80 |
Valuations
| Metric | Date | Value |
|---|---|---|
| 200.98 | ||
| 1.35 | ||
| 1.51 | ||
| 10.32 | ||
| N/A | - |
Balance Sheet
| Metric | Date | Value |
|---|---|---|
| $693.11M | ||
| $238.42M | ||
| $1.26B | ||
| $547.97M | ||
| $571.81M | ||
| $120.59M | ||
| $418.20M | ||
| $9.84M | ||
| $15.15M |
Expenses
| Metric | Date | Value |
|---|---|---|
| $719.38M | ||
| $491.27M | ||
| $207.04M | ||
| $326.89M | ||
| $91.02M | ||
| $0.00 | ||
| $9.84M |
Cash Flow
| Metric | Date | Value |
|---|---|---|
| $151.99M | ||
| $99.48M | ||
| -$369.63M | ||
| $15.33M | ||
| $136.66M |
Recent analyst updates
| Metric | Date | Value |
|---|---|---|
| RBC Capital | → | |
| Needham | → | |
| Barclays | → | |
| Needham | → | |
| HC Wainwright & Co. | → | |
| Barclays | ||
| Truist Securities | → | |
| Needham | → | |
| Needham | → | |
| HC Wainwright & Co. | → |
Analyst sentiment
Institutional ownership
Screeners with PCRX
FAQ
What is the ticker symbol for Pacira BioSciences, Inc.?
The ticker symbol for Pacira BioSciences, Inc. is NASDAQ:PCRX
Does Pacira BioSciences, Inc. pay dividends?
No, Pacira BioSciences, Inc. does not pay dividends
What sector is Pacira BioSciences, Inc. in?
Pacira BioSciences, Inc. is in the Healthcare sector
What industry is Pacira BioSciences, Inc. in?
Pacira BioSciences, Inc. is in the Specialty & Generic Drug Manufacturers industry
What country is Pacira BioSciences, Inc. based in?
Pacira BioSciences, Inc. is headquartered in United States
When did Pacira BioSciences, Inc. go public?
Pacira BioSciences, Inc. initial public offering (IPO) was on February 3, 2011
Is Pacira BioSciences, Inc. in the S&P 500?
No, Pacira BioSciences, Inc. is not included in the S&P 500 index
Is Pacira BioSciences, Inc. in the NASDAQ 100?
No, Pacira BioSciences, Inc. is not included in the NASDAQ 100 index
Is Pacira BioSciences, Inc. in the Dow Jones?
No, Pacira BioSciences, Inc. is not included in the Dow Jones index
When was Pacira BioSciences, Inc. last earnings report?
Pacira BioSciences, Inc.'s most recent earnings report was on April 30, 2026
When does Pacira BioSciences, Inc. report earnings?
The next expected earnings date for Pacira BioSciences, Inc. is August 4, 2026
Data Sources & References
- PCRX Official Website www.pacira.com
- Most Recent Annual Report (10-K) www.sec.gov/Archives/edgar/data/1396814/000162828026012297/0001628280-26-012297-index.htm
- PCRX Profile on Yahoo Finance finance.yahoo.com/quote/PCRX
- PCRX Profile on NASDAQ.com www.nasdaq.com/market-activity/stocks/pcrx